UBS Group AG Purchases 318,113 Shares of Editas Medicine, Inc. (NASDAQ:EDIT)
UBS Group AG lifted its position in shares of Editas Medicine, Inc. (NASDAQ:EDIT – Get Rating) by 357.8% during the 4th quarter, HoldingsChannel.com reports. The firm owned 407,014 shares of the company’s stock after buying an additional 318,113 shares during the quarter. UBS Group AG’s holdings in Editas Medicine were worth $3,610,000 at the end […]